Ovid Therapeutics Inc (OVID)

Jul 22, 2025

Is Ovid Therapeutics Inc. a good long term investmentRapid wealth multiplication - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

July 2025's Top Penny Stocks To Watch - simplywall.st

Jul 22, 2025

Jul 22, 2025

What drives Ovid Therapeutics Inc. stock priceFree Capital Growth Strategies - printweek.in

Jul 22, 2025

Jul 22, 2025

What analysts say about Ovid Therapeutics Inc. stockPhenomenal returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Ovid Therapeutics Stock Soars 13.88% on Investor Optimism - AInvest

Jul 22, 2025

Jul 20, 2025

Ovid Therapeutics Inc. Stock Analysis and ForecastFree Predictions - Autocar Professional

Jul 20, 2025

Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 19, 2025

Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 19, 2025

Jul 18, 2025

What makes Ovid Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 18, 2025

Jul 17, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jul 17, 2025

Jul 17, 2025

Ovid Therapeutics Surges 25% Amid Analyst Hype and Strategic Pipeline Progress - AInvest

Jul 17, 2025

Jul 15, 2025

Why Ovid Therapeutics Inc. stock attracts strong analyst attentionDaily Breakout Picks - Newser

Jul 15, 2025

Jul 15, 2025

How Ovid Therapeutics Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 15, 2025

Jul 15, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Price Down 2% – Time to Sell? - Defense World

Jul 15, 2025

Jul 11, 2025

Ovid Therapeutics Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 11, 2025

Jul 10, 2025

Local Bounti (LOCL) insider files Form 144 to sell 3,500 shares - Stock Titan

Jul 10, 2025

Jun 25, 2025

Ovid Therapeutics Sells Ganaxolone Royalties to Immedica - TipRanks

Jun 25, 2025

Jun 17, 2025

Balance Sheet Insights: Ovid Therapeutics Inc (OVID)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Jun 17, 2025

Jun 15, 2025

Stoke Therapeutics: Impressive Pipeline And Big Backers - Seeking Alpha

Jun 15, 2025

Jun 13, 2025

Ovid Therapeutics Inc (OVID) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jun 13, 2025

Jun 13, 2025

Rising Leaders 2025: Ovid’s Meg Alexander On Neurology’s Next Frontier - insights.citeline.com

Jun 13, 2025

Jun 13, 2025

Safety scares and trial misses drag down neuro biotechs into Q2 - BioWorld MedTech

Jun 13, 2025

Jun 12, 2025

Transcript : Ovid Therapeutics Inc.Special Call - MarketScreener

Jun 12, 2025

Jun 11, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jun 11, 2025

Jun 09, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results - mx.advfn.com

Jun 09, 2025

Jun 05, 2025

Ovid Therapeutics (OVID) to Showcase Biomarker Advances in Epile - GuruFocus

Jun 05, 2025

Jun 05, 2025

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025 | OVID Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025 - GlobeNewswire

Jun 05, 2025

Jun 05, 2025

Harvard Expert to Present Breakthrough Epilepsy Treatment Data at Ovid Therapeutics Event - Stock Titan

Jun 05, 2025

Jun 01, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 01, 2025

May 30, 2025

HC Wainwright Predicts Weaker Earnings for Ovid Therapeutics - Defense World

May 30, 2025

May 28, 2025

Ovid Therapeutics (NASDAQ:OVID) Price Target Cut to $1.50 by Analysts at HC Wainwright - Defense World

May 28, 2025

May 28, 2025

Ovid Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 28, 2025

May 27, 2025

Ovid Therapeutics (OVID): HC Wainwright & Co. Lowers Price Targe - GuruFocus

May 27, 2025

May 27, 2025

Ovid Therapeutics (OVID): Price Target Revised Amid Future Growt - GuruFocus

May 27, 2025

May 27, 2025

Ovid Therapeutics (OVID): Price Target Revised Amid Future Growth Prospects | OVID Stock News - GuruFocus

May 27, 2025

May 20, 2025

Brokerages Set Ovid Therapeutics Inc. (NASDAQ:OVID) PT at $3.03 - Defense World

May 20, 2025